Redlands, CA, United States of America

David J Baylink

This inventor holds 24 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Gene Therapy. Top assignees: Loma Linda University, The United States Government as Represented by the Department of Veterans Affairs, Colgate Palmolive Company. Active years: 1989-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Baylink. Retrieved from https://idiyas.com/inventor/david-j-baylink

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 83.3


 

Average Co-Inventor Count = 1.9

ph-index = 7

Forward Citations = 228(Granted Patents)


Location History:

  • Loma Linda, CA (US) (2010 - 2014)
  • Redlands, CA (US) (1989 - 2020)

Company Filing History:


Years Active: 1989-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cytokine Storm
Gene Therapy
Osteogenic Therapy
Dendritic Cells
Inflammation Treatment
iPS Cells
Bone Resorption
Fluoride Medication
Growth Factors
Pharmaceutical Agents
Bone-Wasting Diseases
Porous Matrix
24 patents (USPTO):Explore Patents

Title: David J Baylink: Innovator in Dendritic Cell Research

Introduction

David J Baylink is a prominent inventor based in Redlands, California, recognized for his significant contributions to the field of biotechnology and stem cell research. With an impressive portfolio of 22 patents, he has been at the forefront of developing innovative methods for treating inflammation-related conditions and advancing stem cell technology.

Latest Patents

Among his latest patents, Baylink has designed a method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells, thereby offering new avenues for treating gut inflammation. His technology involves gene-modified, lymphoid-tissue-homing dendritic cells that express a 1-alpha-hydroxylase gene and a retinaldehyde dehydrogenase 2 gene. These genes are crucial for generating functional enzymes that play significant roles in the immune response.

Another noteworthy patent discusses vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells. This innovative method outlines the application of a vector backbone along with transcription and reprogramming factor genes, which are critical in creating induced pluripotent stem cells free from genetic integration. This advancement stands to revolutionize regenerative medicine by enhancing the efficiency and safety of stem cell generation.

Career Highlights

Throughout his career, David Baylink has collaborated with esteemed organizations, including Loma Linda University, where he has been involved in groundbreaking research and development in the biomedical field. His work has enabled significant advancements that could lead to improved treatment options for patients suffering from various inflammatory conditions.

Collaborations

Baylink has worked alongside notable colleagues, including Kin-Hing William Lau and Subburaman Mohan, who share his passion for innovation in medical research. Together, they have contributed significantly to the understanding and application of dendritic cell technologies and stem cell therapeutics.

Conclusion

David J Baylink continues to push the boundaries of scientific innovation, driven by his commitment to improving human health through biotechnology. His extensive patent portfolio not only reflects his creativity and expertise but also underscores the potential impact of his work on medical treatments and therapies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…